Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had revenue of $58.30M in the quarter ending March 31, 2026, with 104.43% growth. This brings the company's revenue in the last twelve months to $204.89M, up 150.30% year-over-year. In the year 2025, Phathom Pharmaceuticals had annual revenue of $175.11M with 216.93% growth.

• Revenue (ttm): $204.89M
• Revenue Growth: +150.30%
• P/S Ratio: 4.34
• Revenue / Employee: $552,270
• Employees: 371
• Market Cap: 961.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	175.11M	119.86M	216.93%
Dec 31, 2024	55.25M	54.57M	8,001.47%
Dec 31, 2023	682.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 1, 2026

Data Sources Report a data error